411080 — Sands Lab Balance Sheet
0.000.00%
- KR₩129bn
- KR₩95bn
- KR₩8bn
Annual balance sheet for Sands Lab, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,580 | 5,290 | 7,012 | 32,379 | 34,694 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,025 | 1,651 | 438 | 5,964 | 956 |
Prepaid Expenses | |||||
Total Current Assets | 3,632 | 6,955 | 7,454 | 38,901 | 36,724 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 290 | 584 | 1,511 | 2,839 | 7,654 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 5,517 | 7,999 | 9,776 | 46,362 | 50,354 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,382 | 3,068 | 7,751 | 5,717 | 2,710 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1,382 | 3,131 | 7,778 | 5,743 | 2,719 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 4,134 | 4,868 | 1,998 | 40,619 | 47,635 |
Total Liabilities & Shareholders' Equity | 5,517 | 7,999 | 9,776 | 46,362 | 50,354 |
Total Common Shares Outstanding |